The pro-apoptotic functions of JNKs have been implicated in the pathology of several diseases, including Alzheimer's disease and type 2 diabetes, and, as such, JNK inhibition has been proposed as a treatment for these conditions (Bogoyevitch et al., 2004; Manning and Davis, 2003). Here, MAPK8 is linked to Alzheimer disease.